Cardioprotective Effect of Diazoxide Is Mediated by Activation of Sarcolemmal but Not Mitochondrial ATP-Sensitive Potassium Channels in Mice
MasashiSuzuki, TomoakiSaito, ToshiakiSato, MasajiTamagawa, TakashiMiki, SusumuSeino, HaruakiNakaya
Abstract
MasashiSuzuki, TomoakiSaito, ToshiakiSato, MasajiTamagawa, TakashiMiki, SusumuSeino, HaruakiNakaya
Abstract
Background— We recently demonstrated that the sarcolemmal ATP-sensitive potassium (sarcKATP) channel plays a key role in cardioprotection against ischemia/reperfusion injuries in Kir6.2-knockout (KO) mice. In the present study, we evaluated the effects of diazoxide, a mitochondrial ATP-sensitive potassium (mitoKATP) channel opener, on ischemia-induced myocardial stunning in sarcKATP channel-deficient mice. Methods and Results— Langendorff-perfused hearts of wild-type (WT) and KO mice were subjected to global ischemia/reperfusion. Diazoxide improved the recovery of contractile function in WT hearts but not in KO hearts. Treatment with HMR1098 (a sarcKATP channel blocker) but not 5-hydroxydecanoate (a mitoKATP channel blocker) abolished the cardioprotective effect of diazoxide in WT hearts. In coronary-perfused WT ventricular muscle preparations, action potential shortening during ischemia was accelerated in the presence of diazoxide. Conclusions— Diazoxide enhances action potential shortening during ischem...
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background— We recently demonstrated that the sarcolemmal ATP-sensitive potassium (sarcKATP) channel plays a key role in cardioprotection against ischemia/reperfusion injuries in Kir6.2-knockout (KO) mice. In the present study, we evaluated the effects of diazoxide, a mitochondrial ATP-sensitive potassium (mitoKATP) channel opener, on ischemia-induced myocardial stunning in sarcKATP channel-deficient mice. Methods and Results— Langendorff-perfused hearts of wild-type (WT) and KO mice were subjected to global ischemia/reperfusion. Diazoxide improved the recovery of contractile function in WT hearts but not in KO hearts. Treatment with HMR1098 (a sarcKATP channel blocker) but not 5-hydroxydecanoate (a mitoKATP channel blocker) abolished the cardioprotective effect of diazoxide in WT hearts. In coronary-perfused WT ventricular muscle preparations, action potential shortening during ischemia was accelerated in the presence of diazoxide. Conclusions— Diazoxide enhances action potential shortening during ischem...
Key concepts: Diazoxide, Potassium channel, Cardioprotection, Medicine, Ischemia, ATP-sensitive potassium channel, Stunning, Internal medicine